SCHEMBL21236415

SCHEMBL21236415

CC1(C)OB(c2cc3c(cc2-c2ccc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)cc2)oc2ccccc23)OC1(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LPL P06858 2/20 0.40
▸ LIPG Q9Y5X9 2/20 0.40
▸ PGR P06401 1/20 0.36
▸ AHR P35869 2/20 0.35
▸ MAPT P10636 8/20 0.34
▸ KMT2A Q03164 6/20 0.34
▸ MEN1 O00255 5/20 0.34
▸ ALDH1A1 P00352 5/20 0.33
▸ KDM4E B2RXH2 3/20 0.33
▸ TSHR P16473 2/20 0.33
▸ POLB P06746 2/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ HTT P42858 2/20 0.33
▸ NPC1 O15118 2/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33
▸ MAOA P21397 1/20 0.33
▸ PDGFRB P09619 1/20 0.32
▸ KDR P35968 1/20 0.32
▸ LMNA P02545 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23730997 0.97 LPL (0.39) LPLLIPGPGRAHRMAPT
SCHEMBL23730994 0.91 PGR (0.39) LPLLIPGPGRAHRMAPT
SCHEMBL23105616 0.86 LPL (0.38) LPLLIPGPGRAHRMAPT
SCHEMBL31643463 0.86 LPL (0.38) LPLLIPGPGRAHRMAPT
SCHEMBL24841672 0.83 LPL (0.41) LPLLIPGPGRAHRMAPT
SCHEMBL25871494 0.83 LIPG (0.55) LPLLIPGAHRMAPTKMT2A
SCHEMBL25582666 0.83 LPL (0.41) LPLLIPGAHRMAPTKMT2A
SCHEMBL21891288 0.83 ALOX5 (0.36) LPLLIPGMAPTKMT2AMEN1
SCHEMBL21926365 0.83 LPL (0.37) LPLLIPGPGRAHRMAPT
SCHEMBL21926811 0.83 LPL (0.35) LPLLIPGMAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3527564-B1 NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME LG CHEMICAL LTD (KR) 2022-03-02 — — EP disclosed
US-11228001-B2 Hetero-cyclic compound and organic light emitting device comprising the same LG CHEM, LTD. (KR) 2022-01-18 — — US disclosed
EP-3527564-A1 NOVEL HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT USING SAME LG Chem, Ltd. (KR) 2019-08-21 — — EP disclosed
US-20190245149-A1 NOVEL HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LG CHEM, LTD. (KR) 2019-08-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190245149-A1 NOVEL HETERO-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CYBA, TMEM109 LPL 2396/4885LIPG 2681/4885PGR 1388/4885
US-11228001-B2 Hetero-cyclic compound and organic light emitting device comprising the same CRY1, CYBA, TMEM109 LPL 2027/4885LIPG 2514/4885PGR 1228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback